Age

Visit number vs Reactive hyperemia index: Framingham
N Mean StdDev Median Min Max Unknown Total
Baseline 291 0.5 ± 0.4 0.4 0.004 1.5 27 318
Follow-up 271 0.5 ± 0.4 0.5 0.003 2.1 30 301
Treatment Arm vs Reactive hyperemia index: Framingham
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 291 0.5 ± 0.4 0.4 0.004 1.5 27 318
Healthy Lifestyles and Sleep Education - control arm (HLSE) 98 0.6 ± 0.4 0.5 0.01 1.5 8 106
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 98 0.4 ± 0.3 0.4 0.004 1.3 8 106
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 95 0.5 ± 0.3 0.4 0.02 1.4 11 106
Treatment Arm vs Reactive hyperemia index: Framingham
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 271 0.5 ± 0.4 0.5 0.003 2.1 30 301
Healthy Lifestyles and Sleep Education - control arm (HLSE) 90 0.6 ± 0.4 0.5 0.01 2.1 10 100
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 89 0.5 ± 0.4 0.5 0.01 1.7 12 101
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 92 0.5 ± 0.3 0.4 0.003 1.3 8 100
Age category vs Reactive hyperemia index: Framingham
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 291 0.5 ± 0.4 0.4 0.004 1.5 27 318
45-54 years 49 0.5 ± 0.3 0.5 0.04 1.2 4 53
55-64 years 127 0.5 ± 0.3 0.4 0.01 1.5 12 139
65 years or older 115 0.5 ± 0.4 0.4 0.004 1.4 11 126
Age category vs Reactive hyperemia index: Framingham
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 271 0.5 ± 0.4 0.5 0.003 2.1 29 300
45-54 years 44 0.5 ± 0.3 0.5 0.03 1.2 5 49
55-64 years 113 0.5 ± 0.4 0.4 0.01 1.6 14 127
65 years or older 114 0.6 ± 0.4 0.5 0.003 2.1 10 124
Gender of the participant vs Reactive hyperemia index: Framingham
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 291 0.5 ± 0.4 0.4 0.004 1.5 27 318
Female 79 0.7 ± 0.4 0.7 0.01 1.5 5 84
Male 212 0.4 ± 0.3 0.3 0.004 1.4 22 234
Gender of the participant vs Reactive hyperemia index: Framingham
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 271 0.5 ± 0.4 0.5 0.003 2.1 30 301
Female 73 0.7 ± 0.4 0.8 0.01 1.6 6 79
Male 198 0.5 ± 0.3 0.4 0.003 2.1 24 222
Race of the participant vs Reactive hyperemia index: Framingham
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 290 0.5 ± 0.4 0.4 0.01 1.5 27 317
White 234 0.5 ± 0.3 0.4 0.01 1.4 22 256
American Indian or Alaskan Native 2 0.4 ± 0.5 0.4 0.1 0.8 - 2
Black or African American 38 0.7 ± 0.4 0.7 0.01 1.5 5 43
Asian 6 0.5 ± 0.4 0.4 0.2 1.0 - 6
Native Hawaiian or other Pacific islander 1 1.4 - 1.4 1.4 1.4 - 1
Other 4 0.5 ± 0.5 0.5 0.1 1.1 - 4
Multiple 5 0.3 ± 0.3 0.3 0.01 0.7 - 5
Race of the participant vs Reactive hyperemia index: Framingham
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 271 0.5 ± 0.4 0.5 0.003 2.1 28 299
White 219 0.5 ± 0.4 0.4 0.003 2.1 22 241
American Indian or Alaskan Native 1 0.03 - 0.03 0.03 0.03 1 2
Black or African American 37 0.7 ± 0.4 0.7 0.01 1.4 4 41
Asian 6 0.7 ± 0.3 0.8 0.1 0.9 - 6
Native Hawaiian or other Pacific islander 1 1.2 - 1.2 1.2 1.2 - 1
Other 3 0.8 ± 0.5 1.0 0.2 1.1 - 3
Multiple 4 0.6 ± 0.3 0.6 0.4 0.9 1 5